BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Checkpoint inhibitors
1
Combinations of lenvatinib and immune checkpoint inhibitors plus transarterial chemoembolization, is it the prime time for unresectable hepatocellular carcinoma?
11/12/2024 12:23:36 PM | Browse: 129 | Download: 565
2
Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept
4/24/2024 8:35:39 AM | Browse: 154 | Download: 560
3
Implication of gut microbiome in immunotherapy for colorectal cancer
9/9/2022 12:48:14 PM | Browse: 632 | Download: 1739
4
Checkpoint inhibitor-induced hepatotoxicity: Role of liver biopsy and management approach
7/27/2022 1:17:37 PM | Browse: 535 | Download: 1355
5
Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma
1/22/2022 6:17:12 AM | Browse: 689 | Download: 1476
6
Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
7/6/2019 6:23:58 AM | Browse: 1565 | Download: 2793
7
Checkpoint inhibitors: What gastroenterologists need to know
12/27/2018 8:56:32 AM | Browse: 991 | Download: 1704
8
Drug resistance and new therapies in colorectal cancer
9/14/2018 5:53:04 AM | Browse: 1355 | Download: 1885
9
Use of programmed cell death protein ligand 1 assay to predict the outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors
8/8/2017 1:51:46 AM | Browse: 1203 | Download: 2094
10
Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality
5/6/2017 8:30:21 PM | Browse: 1232 | Download: 1907
11
From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis
2/8/2017 3:24:00 PM | Browse: 1253 | Download: 1953
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.